SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF

Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds are contemplated for use in the treatment of conditions such as depression and related disorders. Orally available formulations and other pharmaceutically acceptable delivery forms of the comp...

Full description

Saved in:
Bibliographic Details
Main Authors LOWE John A. III, KHAN M. Amin
Format Patent
LanguageEnglish
Slovenian
Published 31.03.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds are contemplated for use in the treatment of conditions such as depression and related disorders. Orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
AbstractList Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds are contemplated for use in the treatment of conditions such as depression and related disorders. Orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
Author LOWE John A. III
KHAN M. Amin
Author_xml – fullname: LOWE John A. III
– fullname: KHAN M. Amin
BookMark eNrjYmDJy89L5WQwCw7wDPLX9XF0DnH0VfDzdXFUCHJ1dg0I8Q9S8PV3CfVxBLKCFRz9XBRCg12DFUI8XINc_d14GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakl8sKexqaGJoalFSIihMTFqACeZKjE
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate Spirolaktamski modulatorji NMDA-receptorja in njihove uporabe
ExternalDocumentID SI3514158TT1
GroupedDBID EVB
ID FETCH-epo_espacenet_SI3514158TT13
IEDL.DBID EVB
IngestDate Fri Jul 19 12:52:21 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Slovenian
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_SI3514158TT13
Notes Application Number: SI20140032009T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230331&DB=EPODOC&CC=SI&NR=3514158T1
ParticipantIDs epo_espacenet_SI3514158TT1
PublicationCentury 2000
PublicationDate 20230331
PublicationDateYYYYMMDD 2023-03-31
PublicationDate_xml – month: 03
  year: 2023
  text: 20230331
  day: 31
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies Aptinyx Inc
RelatedCompanies_xml – name: Aptinyx Inc
Score 3.461088
Snippet Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds are contemplated for use in the treatment of...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230331&DB=EPODOC&locale=&CC=SI&NR=3514158T1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LSwMxEB5KFfWmVbH1QQTpbbHPbHtYZJtkaaX7YDeV3sqmzUJB2mJX_PtO1la96G1IYJgEvnlkHgF4oLS_6GWaWik6w1ZHN6ml2hnFKEXrzNgLe24yun5Ah5PO87Q7LcFy3wtTzAn9KIYjIqLmiPe80Nebn0csXtRWbh_VEpfWT550eH0XHaM_bRqA-MARUchDVmfMSUb1IHZMwXqz25MYKB2gF20bMIiXgWlK2fy2KN4pHEbIbJWfQWn7WoFjtv94rQJH_i7fjeQOettzoEk0ikNr7DLp-iTwuUtiwUQkw5j4IZ-MXaQS4gacTFBHEjkUsQi9C7j3hGRDCwWYfR92loz2ospm-xLKq_VKXwGxF2nDxtCktcjmHa0afd1NKTpLqVJU2apVhdrffGr_bV7Dibm4rz67Gyjnb-_6Fg1tru6KK_oEmVR9nQ
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq6L1FUF6C_a5aQ9B0t0NieZFspXeSrbdQEHaYiP-fSexVS96G3ZhmF345rHzWIB7QobzQaaInqIzrPdUm-iymxGMUpTKCnthzIqMrh8QZ9x7mvQnFVjsemHKOaEf5XBERNQM8Z6X-nr984jFytrKzYNc4NLq0RYma26jY_SniwYgNjJ5FLKQNik1E7cZxGZRsN7uDwQGSnvoYRsFGPjLqGhKWf-2KPYR7EfIbJkfQ2XzWoca3X28VocDf5vvRnILvc0JkCRy41D3LCosXwt8ZmkxpzwSYaz5IRt7FlKJZgVMG6OO1ITDYx7ap3Bnc0EdHQWYfh92mrg7UUW7ewbV5WqpzkEz5mnLwNCkM89mPSVbQ9VPCTpLqZREGrJzAY2_-TT-27yFmiN8b-q5wfMlHBaX-NVzdwXV_O1dXaPRzeVNeV2fqOuAkA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SPIRO-LACTAM+NMDA+RECEPTOR+MODULATORS+AND+USES+THEREOF&rft.inventor=LOWE+John+A.+III&rft.inventor=KHAN+M.+Amin&rft.date=2023-03-31&rft.externalDBID=T1&rft.externalDocID=SI3514158TT1